CASI Pharmaceuticals, Inc. (CASIF) stock
CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
CASI Pharmaceuticals gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2025 it was 48.6%, against 39.1% the year before. The highest annual figure on record is 63.3% in fiscal 2022.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 48.6% | +9.6 |
| FY2024 | Dec 31, 2024 | 39.1% | −20.1 |
| FY2023 | Dec 31, 2023 | 59.2% | −4.1 |
| FY2022 | Dec 31, 2022 | 63.3% | +4.9 |
| FY2021 | Dec 31, 2021 | 58.4% | +21.2 |
| FY2020 | Dec 31, 2020 | 37.2% | – |
See a number that looks wrong?